Abstract:Sphingolipids play a very important role in cell membrane formation, signal transduction, and plasma lipoprotein metabolism, and all these functions may have an impact on atherosclerotic development. Serine palmitoyl-CoA transferase (SPT) is the key enzyme in sphingolipid biosynthesis. To evaluate in vivo SPT activity and its role in sphingolipid metabolism, we applied homologous recombination to embryonic stem cells, producing mice with long chain base 1 (Sptlc1) and long chain base 2 (Sptlc2), two subunits of SPT, gene deficiency. Homozygous Sptlc11 and Sptlc2 mice are embryonic lethal, whereas heterozygous versions of both animals (Sptlc1+/−, Sptlc2+/−) are healthy. Analysis showed that, compared with WT mice, Sptlc1+/− and Sptlc2+/− mice had: (1) decreased liver Sptlc1 and Sptlc2 mRNA by 44% and 57% (P<0.01 and P<0.0001, respectively); (2) decreased liver Sptlc1 mass by 50% and Sptlc2 mass by 70% (P<0.01 and P<0.01, respectively), moreover, Sptlc1 mass decreased by 70% in Sptlc2+/− mouse liver, while Sptlc2 mass decreased by 53% in Sptlc1+/− mouse liver (P<0.001 and P<0.01, respectively); (3) decreased liver SPT activity by 45% and 60% (P<0.01, respectively); (4) decreased liver ceramide (22% and 39%, P<0.05 and P<0.01, respectively) and sphingosine levels (22% and 31%, P<0.05 and P<0.01, respectively); (5) decreased plasma ceramide (45% and 39%, P<0.01, respectively), sphingosine-1-phosphate (31% and 32%, P<0.01, respectively) and sphingosine levels (22.5% and 25%, P<0.01, respectively); (6) dramatically decreased plasma lysosphingomyelin (17-fold and 16-fold, P<0.0001, respectively); and (7) no change of plasma sphingomyelin, triglyceride, total cholesterol, phospholipids, and liver sphingomyelin levels. These results indicated that both Sptlc1 and Sptlc2 interactions are necessary for SPT activity in vivo, and that SPT activity directly influences plasma sphingolipid levels. Furthermore, manipulation of SPT activity might well influence the course of such diseases as atherosclerosis.

SPNS1 is required for the transport of lysosphingolipids and lysoglycerophospholipids from lysosomes

Lack of SPNS1 results in accumulation of lysolipids and lysosomal storage disease in mouse models

Spns1 is a lysophospholipid transporter mediating lysosomal phospholipid salvage

Loss of SPNS1, a lysosomal transporter, in the nervous system causes dysmyelination and white matter dysplasia

The Role of Sphingosine-1-Phosphate Transporter Spns2 in Immune System Function

Sphingosine 1-phosphate lyase ablation disrupts presynaptic architecture and function via an ubiquitin- proteasome mediated mechanism

An SPNS1-dependent lysosomal lipid transport pathway that enables cell survival under choline limitation

Structural basis of Sphingosine-1-phosphate transport via human SPNS2

Spns1 is an iron transporter essential for megalin-dependent endocytosis.

Molecular basis of Spns2-facilitated sphingosine-1-phosphate transport

Site-1 protease and lysosomal homeostasis

Serine Palmitoyl-Coa Transferase (SPT) Deficiency and Sphingolipid Levels in Mice.

Mfsd2a and Spns2 are essential for sphingosine-1-phosphate transport in the formation and maintenance of the blood-brain barrier.

Lysophosphatidic Acid Signaling Via LPA6: A Negative Modulator of Developmental Oligodendrocyte Maturation

Childhood amyotrophic lateral sclerosis caused by excess sphingolipid synthesis

Adipocyte-Specific Deficiency of De Novo Sphingolipid Biosynthesis Leads to Lipodystrophy and Insulin Resistance

MFSD12 affects glycosphingolipid metabolism by modulating lysosome homeostasis

Severe kidney dysfunction in sialidosis mice reveals an essential role for neuraminidase 1 in reabsorption

Sphingolipid Metabolism Is Dysregulated at Transcriptomic and Metabolic Levels in the Spinal Cord of an Animal Model of Amyotrophic Lateral Sclerosis

A Novel Function of Sphingosine Kinase 2 in the Metabolism of Sphinga-4,14-Diene Lipids

A key enzyme in the biogenesis of lysosomes is a protease that regulates cholesterol metabolism